ArticleOpen forum infectious diseases2019

Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly.

Sharon E Frey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.